Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas - Wikidata - awgldk - TriplyDB

Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas

Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas

http://www.wikidata.org/entity/Q35994721

about

Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas Stromelysin-3 is expressed by aggressive meningiomas The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.Matrix metalloproteinases and their inhibitors in canine mammary tumors A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins.Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis Serum metalloproteinases and their inhibitors: markers for malignant potential.Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo.Matrilysin expression and function in airway epithelium.MMP expression profiling in recurred stage IB lung cancer.Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours.Establishment and characterization of a novel human pancreatic cancer cell line (SUIT-4) metastasizing to lymph nodes and lungs in nude mice.Matrix metalloproteinases and their inhibitors in tumor progression.Matrix metalloproteases and lung disease.Stromelysin-3 expression by mammary tumor-associated fibroblasts under in vitro breast cancer cell induction.Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38.Regulation of matrix metalloproteinases following cellular transformation.The biochemistry of cancer dissemination.Curcumin treatment alters ERK-1/2 signaling in vitro and inhibits nasopharyngeal carcinoma proliferation in mouse xenografts.Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.Pair-wise comparison analysis of differential expression of mRNAs in early and advanced stage primary colorectal adenocarcinomas.Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders.Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.Increased release and activity of matrix metalloproteinase-9 in patients with mandibuloacral dysplasia type A, a rare premature ageing syndrome.Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.Developmental expression of MMP-9 (gelatinase B) mRNA in mouse embryos.Expression and localization of mRNAs for matrix metalloproteinases and their inhibitors in mixed bronchioloalveolar carcinomas with invasive components.Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients.

P2860

Q24649857-543D02C9-F70E-4045-ADDD-6047109128C6 Q28202788-3C179A4C-8E8C-4E1E-8FE1-A2338447DCFB Q33634208-1662ACAA-635B-4A02-AF2F-1322A7BB7DCE Q34293732-09F02F0D-A536-441D-A413-134263941859 Q35121300-617049C7-F391-4DFD-A9D1-C44BA58EE689 Q35319993-783147F3-70A7-4F6A-B96D-2D0E9BF520B7 Q35782174-D0651D3C-28AC-4744-8901-3FF8D3AC7435 Q36079649-A1DC7349-DBD4-4B58-88EC-BFB4C9DEC2D9 Q36081231-3D88F4FA-DC00-472B-97A3-89B213714848 Q36135135-8FC4E48F-81F4-45B8-A955-09990CDC692E Q36367835-DDA2DA1E-2102-40D1-B0A3-198FDEEC2CE3 Q37385157-97EC547C-F4E0-4E0B-B0F5-A3B41AC4B4E2 Q38449929-C7200B11-2100-4A7A-8E1C-72D4574E2DC9 Q39704301-03949664-A7DE-43BC-A4B1-76A06B8AD45B Q40510076-142AF4DD-D9E9-42EA-9411-DE217A49EEB3 Q40642341-B8BBB379-0F3D-4ADD-8F18-A06593169FD2 Q40664303-574FE064-2E02-456C-A276-9CAC55FF85C4 Q40718673-6FDC09C3-F10B-42C4-87CD-8FCFC78CEA03 Q40983568-AA3AABE7-5FAF-4CD2-9C44-DFB583407648 Q41209328-591068C7-445A-4F67-8FDB-E96CAC6CD2D7 Q41547351-BAB096E9-2E65-46C1-813A-B0E22D0DEB70 Q41891609-49577645-A556-4BA0-A526-7FDD9D954968 Q42022050-03E63B01-3AAC-4A18-96D6-92522820F9D3 Q42139787-0F54ABE8-5CFF-4443-AC9C-0A4CA10A5C68 Q42270789-EEE4828C-FEDC-4F7C-A041-53789B5D1AB4 Q42471754-2B0F829C-CA5B-4EB2-A58A-88E094124251 Q42590638-02162BC1-4F62-4A88-9A7E-C5D6F9B6350C Q42827266-40449F8D-425F-4085-9265-E1E1A4840FB5 Q44550613-53EC4943-1EE6-4178-B5AC-E5DA3B059A65 Q46433276-AA7DD4AB-A618-45FB-BE4E-95648D70D731 Q52206181-E9DFDD15-4B54-4258-BFDC-ECA3AF0F5E5D Q54681868-D8FD165C-FDF2-40A8-B1B4-E2D789A90874 Q55064253-4EB48368-E6FD-44B4-B872-B9EBAB44FA3F Q55475255-F4F8D040-2595-4C48-BD34-08EB8D0B3068

P2860

Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas

http://www.wikidata.org/entity/Q35994721

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas

@ast

Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas

@en

type

label

Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas

@ast

Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas

@en

prefLabel

Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas

@ast

Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas

@en

P1433

Q35994721-6868FD41-9248-409A-B9A8-9B0F9164C044

P1476

Q35994721-F3ED00F5-8D03-4FA0-9F93-660ECDC01E70

P2093

Q35994721-10951458-0C50-41BB-9AC5-1B5A561894BA

Q35994721-506EBB46-37D6-4A35-A63E-FDF34AB54098

Q35994721-8DDEAE6A-FFF1-47CC-8C02-993249D987BD

Q35994721-9426838C-030B-4BD6-9466-561B4EECDA3B

Q35994721-AF36E801-6A5A-4393-ADEA-1FE5EE85E403

Q35994721-BBA65FCB-8C2E-4E12-9602-D2E24F5F3AD3

P2860

Q35994721-04D094D6-7BF2-4290-ABD4-8D7F4C3CEEA9

Q35994721-2E2C89BC-61E1-4BCE-A41B-A38E94004236

Q35994721-3009FB3A-C58A-49B3-AC51-CB3603F64880

Q35994721-33A531B8-3D82-412B-87EC-3479399A41C8

Q35994721-39C74610-142A-4C72-B5FA-A1424F32E14B

Q35994721-3A063E3B-E519-4DF5-809A-EF4028867DD8

Q35994721-4AD18C4D-4BD2-494A-885E-DD043E0FFF50

Q35994721-5C2019F9-9413-49AD-BD18-0170BB12F797

Q35994721-7437E022-D4CF-48E5-A0B2-934AC15CDA23

Q35994721-7AD7E77B-FEFC-4832-BC53-A89BC42532A9

P2888

Q35994721-4437CA47-397F-4855-9273-28F32ACC4A6A

P304

Q35994721-A74D823E-0675-40AB-BCEC-707347E4A3FF

P31

Q35994721-4A25D572-86BA-41F4-B83E-5CB30E0BF943

P356

Q35994721-BD5986C2-5A27-43CD-9CD0-FB095A70B27B

P407

Q35994721-81053DFD-A343-4DFF-851C-56CF9C2B4D50

P433

Q35994721-A9D4A786-5A5B-4E30-BC3E-65EC860E4529

P478

Q35994721-F36F46C9-BD45-42BF-ABCC-3E1ABB4780B7

P577

Q35994721-BF083172-109D-4AB3-B168-57306B4F0925

P5875

Q35994721-2465EF32-B989-49A1-BCE2-763A40A18272

P698

Q35994721-FA9F5739-1C2C-4708-B191-F1B557689D4A

P932

Q35994721-F403DE2B-0564-406F-BD88-382DE8DF8F07

P356

P1433

British Journal of Cancer

P1476

Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas

@en

P2093

Edwards DR

http://www.w3.org/2001/XMLSchema#string

Kossakowska AE

http://www.w3.org/2001/XMLSchema#string

Leco KJ

http://www.w3.org/2001/XMLSchema#string

Maitland A

http://www.w3.org/2001/XMLSchema#string

Urbanski SJ

http://www.w3.org/2001/XMLSchema#string

Watson A

http://www.w3.org/2001/XMLSchema#string

P2860

The collagenase gene family in humans consists of at least four members

SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages

H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen

A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

Metalloproteinases and their inhibitors in matrix remodeling

cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases.

Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2

Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members.

Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues.

Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.

P2888

P304

1188-1194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1992.434

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

1992-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21699083

http://www.w3.org/2001/XMLSchema#string

P698

1457364

http://www.w3.org/2001/XMLSchema#string

P932

1978055

http://www.w3.org/2001/XMLSchema#string